✦ LIBER ✦

P2.169 Treatment of advanced Parkinson's disease in the United States: a cost-utility model

✍ Scribed by M. Tarrants; H. Groenendaal; C. Armand

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND24 TREATMENT OF ADVANCED PARKINSON'S

✍ ML Tarrants; H Groenendaal; C Armand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Treatment of Advanced Parkinson’s Diseas

✍ Huybert Groenendaal, Dr Marcy L. Tarrants, Christophe Armand 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 163 KB

PND25 The Role of Structural Sensitivity

✍ A.E. Ratcliffe 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

P2.168 Cost-effectiveness of rasagiline

✍ R. Farkouh; M. Wilson; M. Tarrants; J. Castelli-Haley; C. Armand 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

PND32 Cost-Utility Analysis of Ropinirol

✍ I. Zerda; A. Drozdz; D. Brzyski; M. Pochopien; B. Gwiosda; B. Lisiecka; D. Barlo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PND21 COST-EFFECTIVENESS OF RASAGILINE C

✍ R Farkouh; MR Wilson; ML Tarrants; J Castelli-Haley; C Armand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB